Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Cash & Current Investments (2016 - 2026)

Insmed's Cash & Current Investments history spans 17 years, with the latest figure at $1.2 billion for Q1 2026.

  • Quarterly Cash & Current Investments rose 2.01% to $1.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Mar 2026, up 2.01% year-over-year, with the annual reading at $1.4 billion for FY2025, 0.26% changed from the prior year.
  • Cash & Current Investments came in at $1.2 billion for Q1 2026, down from $1.4 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $1.9 billion in Q2 2025 to a low of $513.3 million in Q3 2022.
  • The 5-year median for Cash & Current Investments is $1.1 billion (2022), against an average of $1.1 billion.
  • Year-over-year, Cash & Current Investments crashed 40.35% in 2024 and then skyrocketed 101.34% in 2025.
  • Insmed's Cash & Current Investments stood at $1.1 billion in 2022, then plummeted by 32.03% to $780.4 million in 2023, then skyrocketed by 83.72% to $1.4 billion in 2024, then dropped by 0.26% to $1.4 billion in 2025, then decreased by 14.44% to $1.2 billion in 2026.
  • Per Business Quant, the three most recent readings for INSM's Cash & Current Investments are $1.2 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.7 billion (Q3 2025).